Frederick, Md.
Dynport Vaccine, a joint venture between DynCorp and pharmaceutical company Porton International, has broken ground on a three-story office in Frederick. Dynport Vaccine, the prime systems contractor for the Department of Defense’s vaccine acquisition program, will use the facility to develop biodefense vaccines for FDA production and licensing. The building will consolidate four facilities, as well as providing Department of Defense office space. Architect for the facility is James Lloyd. Developer Manekin of Columbia is building the 60,000-sf office, which is slated for completion by October.
